y 27632 has been researched along with Adenoma, Prostatic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, P; DiSanto, ME; Fu, X; Guo, Y; Li, Y; Liu, D; Liu, H; Qiu, J; Shan, S; Su, M; Wang, X; Wang, Z; Yang, S; Zeng, G; Zhang, J; Zhang, X; Zhou, Y | 1 |
| Adam, R | 1 |
2 other study(ies) available for y 27632 and Adenoma, Prostatic
| Article | Year |
|---|---|
Mechanism of RhoA regulating benign prostatic hyperplasia: RhoA-ROCK-β-catenin signaling axis and static & dynamic dual roles.
Topics: Animals; beta Catenin; Cell Proliferation; Fibrosis; Humans; Male; Prostatic Hyperplasia; Rats; Wnt Signaling Pathway | 2023 |
Rho-kinase inhibitors: potential therapeutics for benign prostate hyperplasia.
Topics: Amides; Enzyme Inhibitors; Humans; Intracellular Signaling Peptides and Proteins; Male; Muscle Contraction; Muscle, Smooth; Prostatic Hyperplasia; Protein Serine-Threonine Kinases; Pyridines; rho-Associated Kinases | 2003 |